Search research articles
Contact Us
Filters
Showing results (51-60 of 167) with videos related to
Page
of 17
Sort By:
United European Gastroenterology Journal
|
December 19, 2024
Evolution of Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials: A Clinical Trial Databank Analysis
An Outtier, Rosanne Janssens, Liese Barbier, et al.
Clinical Pharmacokinetics
|
April 8, 2026
Why the Assay Matters in Model-Informed Precision Dosing: An Example of Ustekinumab in Crohn's Disease
Wei Zhang, Zhigang Wang, Thierry Dervieux, et al.
Endoscopy International Open
|
January 15, 2024
Long-term follow-up of the red density pilot trial: a basis for long-term prediction of sustained clinical remission in ulcerative colitis?
Pieter Sinonquel, Peter Bossuyt, João Pedro Guedelha Sabino, et al.
Inflammatory Bowel Diseases
|
February 24, 2021
Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease
Sare Verstockt, Bram Verstockt, Kathleen Machiels, et al.
Nature Reviews. Gastroenterology & Hepatology
|
April 17, 2023
IL-12 and IL-23 pathway inhibition in inflammatory bowel disease
Bram Verstockt, Azucena Salas, Bruce E Sands, et al.
Digestive Diseases (Basel, Switzerland)
|
February 27, 2025
No Increased Risk of Venous Thromboembolism or Infectious Complications after Janus Kinase Inhibitor Exposure in Patients with Ulcerative Colitis Undergoing Surgery
Ine De Greef, Gabriele Bislenghi, Isabelle Terrasson, et al.
Inflammatory Bowel Diseases
|
August 6, 2024
Eosinophil Depletion as a Potential Therapeutic Strategy in Acute and Chronic Intestinal Inflammation Based on a Dextran Sulfate Sodium Colitis Model
Inge Jacobs, Sara Deleu, Jonathan Cremer, et al.
Inflammatory Bowel Diseases
|
September 7, 2025
Patient-Specific Regulatory Network Rewiring in Inflammatory Bowel Disease: How Genetic Polymorphisms Divert Incoming Signals and Contribute to Disease Pathogenesis
Balazs Bohar, John P Thomas, Yufan Liu, et al.
Alimentary Pharmacology & Therapeutics
|
August 16, 2018
Influence of early adalimumab serum levels on immunogenicity and long-term outcome of anti-TNF naive Crohn's disease patients: the usefulness of rapid testing
Bram Verstockt, Gitte Moors, Sumin Bian, et al.
The American Journal of Gastroenterology
|
July 30, 2025
Inflammatory Bowel Disease and Risk of More than 1,500 Comorbidities: A Disease-wide Prediagnostic and Postdiagnostic Phenomic Association Study
Anthony C Ebert, Bram Verstockt, Martin Bøgsted, et al.
Page
of 17
Search research articles
Search
Showing results (51-60 of 167) with videos related to
Sort By:
Page
of 17
United European Gastroenterology Journal
|
December 19, 2024
Evolution of Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials: A Clinical Trial Databank Analysis
An Outtier, Rosanne Janssens, Liese Barbier, et al.
Clinical Pharmacokinetics
|
April 8, 2026
Why the Assay Matters in Model-Informed Precision Dosing: An Example of Ustekinumab in Crohn's Disease
Wei Zhang, Zhigang Wang, Thierry Dervieux, et al.
Endoscopy International Open
|
January 15, 2024
Long-term follow-up of the red density pilot trial: a basis for long-term prediction of sustained clinical remission in ulcerative colitis?
Pieter Sinonquel, Peter Bossuyt, João Pedro Guedelha Sabino, et al.
Inflammatory Bowel Diseases
|
February 24, 2021
Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease
Sare Verstockt, Bram Verstockt, Kathleen Machiels, et al.
Nature Reviews. Gastroenterology & Hepatology
|
April 17, 2023
IL-12 and IL-23 pathway inhibition in inflammatory bowel disease
Bram Verstockt, Azucena Salas, Bruce E Sands, et al.
Digestive Diseases (Basel, Switzerland)
|
February 27, 2025
No Increased Risk of Venous Thromboembolism or Infectious Complications after Janus Kinase Inhibitor Exposure in Patients with Ulcerative Colitis Undergoing Surgery
Ine De Greef, Gabriele Bislenghi, Isabelle Terrasson, et al.
Inflammatory Bowel Diseases
|
August 6, 2024
Eosinophil Depletion as a Potential Therapeutic Strategy in Acute and Chronic Intestinal Inflammation Based on a Dextran Sulfate Sodium Colitis Model
Inge Jacobs, Sara Deleu, Jonathan Cremer, et al.
Inflammatory Bowel Diseases
|
September 7, 2025
Patient-Specific Regulatory Network Rewiring in Inflammatory Bowel Disease: How Genetic Polymorphisms Divert Incoming Signals and Contribute to Disease Pathogenesis
Balazs Bohar, John P Thomas, Yufan Liu, et al.
Alimentary Pharmacology & Therapeutics
|
August 16, 2018
Influence of early adalimumab serum levels on immunogenicity and long-term outcome of anti-TNF naive Crohn's disease patients: the usefulness of rapid testing
Bram Verstockt, Gitte Moors, Sumin Bian, et al.
The American Journal of Gastroenterology
|
July 30, 2025
Inflammatory Bowel Disease and Risk of More than 1,500 Comorbidities: A Disease-wide Prediagnostic and Postdiagnostic Phenomic Association Study
Anthony C Ebert, Bram Verstockt, Martin Bøgsted, et al.
Page
of 17